These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 31227330)

  • 1. OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema.
    Hsieh YT; Alam MN; Le D; Hsiao CC; Yang CH; Chao DL; Yao X
    Ophthalmol Retina; 2019 Oct; 3(10):826-834. PubMed ID: 31227330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
    Lee J; Moon BG; Cho AR; Yoon YH
    Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macular vessels density in diabetic retinopathy: quantitative assessment using optical coherence tomography angiography.
    AttaAllah HR; Mohamed AAM; Ali MA
    Int Ophthalmol; 2019 Aug; 39(8):1845-1859. PubMed ID: 30194547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of optical coherence tomography angiography in management of diabetic macular edema.
    Basiony AI; Mohamed Gad Marey H; Ezzat Abdel Fattah AM; Aly Zaky M
    BMC Ophthalmol; 2024 Oct; 24(1):429. PubMed ID: 39354390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
    Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
    Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
    Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE.
    Reddy RK; Pieramici DJ; Gune S; Ghanekar A; Lu N; Quezada-Ruiz C; Baumal CR
    Ophthalmology; 2018 Oct; 125(10):1568-1574. PubMed ID: 29752001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA.
    Wirth MA; Wons J; Freiberg FJ; Becker MD; Michels S
    Retina; 2018 Sep; 38(9):1824-1829. PubMed ID: 28767550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between Deep Capillary Plexus Perfusion and Long-Term Photoreceptor Recovery after Diabetic Macular Edema Treatment.
    Moon BG; Um T; Lee J; Yoon YH
    Ophthalmol Retina; 2018 Mar; 2(3):235-243. PubMed ID: 31047592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.
    Karst SG; Lammer J; Mitsch C; Schober M; Mehta J; Scholda C; Kundi M; Kriechbaum K; Schmidt-Erfurth U
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):49-58. PubMed ID: 29080915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy.
    Eraslan S; Yıldırım Ö; Dursun Ö; Dinç E; Orekici Temel G
    Turk J Ophthalmol; 2020 Jun; 50(3):163-168. PubMed ID: 32631004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography biomarkers DROL, PROS, SND, hyperreflective walls of foveal cystoid spaces as predictors of central macular thickness and visual acuity in diabetic macular edema treated with intravitreal ranibizumab.
    Sardana A; Singh K; Singh A; Singh VK
    Indian J Ophthalmol; 2024 May; 72(5):722-727. PubMed ID: 38648434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of optical coherence tomography angiography in the assessment of diabetic macular edema staging and laser photocoagulation efficacy.
    Fu WN; Du Y; Gong ZY
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104055. PubMed ID: 38508440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema: A Subanalysis of the RESTORE (Extension) Study.
    Karst SG; Deak GG; Gerendas BS; Waldstein SM; Lammer J; Simader C; Guerin T; Schmidt-Erfurth UM
    JAMA Ophthalmol; 2018 Apr; 136(4):315-321. PubMed ID: 29494727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical outcomes of different components of diabetic macular edema on optical coherence tomography.
    Hu Y; Wu Q; Liu B; Cao D; Dong X; Zhang L; Li T; Yang X; Yu H
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2613-2621. PubMed ID: 31529324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vessel Density Changes on Optical Coherence Tomography Angiography after Vascular Endothelial Growth Factor Inhibitor Treatment for Diabetic Macular Edema.
    Cheong KX; Lee SY; Ang M; Teo KYC
    Turk J Ophthalmol; 2020 Dec; 50(6):343-350. PubMed ID: 33389934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
    Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A
    Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual Outcomes Following Intravitreal Ranibizumab for Diabetic Macular Edema in a Pro Re Nata Protocol from Baseline: A Real-World Experience.
    James DGP; Mitkute D; Porter G; Vayalambrone D
    Asia Pac J Ophthalmol (Phila); 2019; 8(3):200-205. PubMed ID: 31165603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.